Immunological pathogenesis and treatment of systemic lupus erythematosus.

Lu PanMei-Ping LuJing-Hua WangMeng XuSi-Rui Yang

Published in: World journal of pediatrics : WJP (2019)

Dysregulated immune response plays a critical role in SLE, including innate immunity and adaptive immunity. Biologic agents that aim to specifically target abnormal immune processes were assessing and may bring new hope to SLE patients.

Keyphrases

systemic lupus erythematosus
disease activity
immune response
end stage renal disease
rheumatoid arthritis
newly diagnosed
ejection fraction
prognostic factors
peritoneal dialysis
dendritic cells
toll like receptor
smoking cessation
patient reported